Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Other(2)

Detailed Status

Completed7
Suspended1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (12.5%)
N/A7 (87.5%)

Trials by Status

suspended110%
completed770%
recruiting110%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10